| Trial ID: | L5042 |
| Source ID: | NCT00437164
|
| Associated Drug: |
Insulin
|
| Title: |
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin|DRUG: Oral GW677954 Capsules (15 mg)
|
| Outcome Measures: |
Primary: changes in fluid related parameters as measured by hematocrit and hemoglobin levels and body weight, up to 24 weeks | Secondary: safety/tolerability, as measured by adverse events, clinical laboratory, edema & glycemic measures, ophthalmic assessments; & changes in weight, waist & hip circumference, up to 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
1
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-04
|
| Locations: |
GSK Investigational Site, Beverly Hills, California, 90211, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00437164
|
